BAMCO Inc’s Medtronic MDT Stock Holding History

BAMCO Inc’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,575	Closed	-$234K	–	371
2018 Q4	$234K	Sell	2,575 -147	-5%	-$13.7K	﹤0.01%	324
2018 Q3	$268K	Buy	+2,722	New	+$252K	﹤0.01%	326

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BAMCO Inc's MDT Position: Q1 2019 in Review

BAMCO Inc sold out of Medtronic (MDT) in Q1 2019, closing a stake of 2,575 shares — an estimated $234K sold.

BAMCO Inc first reported a position in MDT in Q3 2018 and held it in 2 quarters. The position peaked at $268K in Q3 2018. 1,602 funds tracked by Wall St. Rank hold MDT as of Q1 2019.

BAMCO Inc reported no remaining Medtronic position as of Q1 2019 after selling out during the quarter.
BAMCO Inc sold 2,575 Medtronic shares in Q1 2019, an estimated $234K.
BAMCO Inc first reported a position in Medtronic in Q3 2018 and held it in 2 quarters.
BAMCO Inc's Medtronic position peaked at $268K in Q3 2018.
1,602 funds tracked by Wall St. Rank held Medtronic as of Q1 2019.

Based on BAMCO Inc's 13F filing for Q1 2019, filed 15 May 2019.